News
Search EMA's news announcements
Megjegyzés a megjelenített nyelvhez
Ez az oldal nem érhető el az Ön által választott nyelven a weboldalon található gépi fordítási szolgáltatáson keresztül.
Az oldal az eredeti angol nyelvű változatban jelenik meg.
Jascayd slowed loss of lung function in patients with idiopathic or progressive pulmonary fibrosis
The European Medicines Agency's (EMA) office is closed from 18:00 on Friday 22 May until 08:30 on Tuesday 26 May
19 multinational clinical trials have been authorised in addition to the historical average; 40.5% of the total number of clinical trials recruit participants within 200 days
Risk for the general population currently considered very low by ECDC
The European Medicines Agency's (EMA) office is closed from 18:00 on Wednesday 13 May until 08:30 on Monday 18 May
Act to improve availability, production and supply of critical medicines in the European Union
PRAC carried out its broad range of responsibilities for managing the risks associated with medicine use
International panel of high-level experts will support EMA’s efforts to strengthen trust in vaccines
Enhanced regulatory support and priority access to scientific advice for developers
Five new medicines recommended for approval; another nine medicines recommended for extension of their therapeutic indications